Antony Currie and Rob Cox discuss how the increasing problems at $1 bln-plus former startup darlings like Theranos are a boon to the incumbent companies they're trying to disrupt.
from Reuters Video: Breakingviews http://ift.tt/1TSVTEH
via IFTTT
No comments:
Post a Comment